ComplianceOnline
News
Best Practices
Compliance Training
Store
Q&A
BII
Welcome,
Guest
Free Registration | Sign In
ComplianceOnline Home > Compliance Training > FDA Training
 Sub Categories .
- FDA Audit and Inspection
- GXP Pharmaceutical
- GXP Medical Devices
- Drug and Device Approvals
- FDA Validation
- FDA 21 CFR Part 11
- Drug Marketing Compliance

How do I keep FDA happy with my contract manufacturer?

This Quality System Regulation training we will review the sections of Quality system regulations, design control regulations which FDA uses as an inspection tool. Actual FDA investigator training methods related to design control inspections. Real life examples of FDA design control compliance issues will be examined.
Training Options Training Duration = 60 Min
$299.00 Access Recorded Version Only
One Person - Unlimited viewing for 6 Months
(For multiple licenses contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
$500.00 Get Training CD Only
One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days
 
Instructor: Dennis Moore
Product ID: 701444
Training Level: Intermediate
Bookmark
 Tell a Friend
Description

Why Should You Attend :
Many companies are confident that their design control system is compliant to the Quality System Regulation, yet FDA conducts an inspection and FDA 483 design control cites are written and warning Letters, seizures or worse ensue. This presentation will review the sections of the QS Reg. design control regulation which represent high compliance risk to firms. Actual design control/FDA data will be discussed, which shows the agencies' design control compliance directions. FDA investigator techniques will also be discussed.

Learning Objectives:

  • What FDA expects and will request from you during your design control portion of your FDA inspection.
  • How QSIT inspections related to design control systems and its attendant record keeping are performed by FDA.
  • How change control issues affect design control inspections.
  • What constitutes a good design control process auditing procedure.
  • How do how to counteract a possible design control FDA 483 cite.
  • How risk management fits into design control compliance.

Areas Covered in the Seminar:

  • Introduction.
  • Guidance documents QS regulation.
  • Major FDA 483 points.
  • Trends in FDA.
  • Determining best practice for the supplier audit.
  • Conducting a thorough audits.
  • FDA import detention prevention.
  • Questions to ask during the supplier audit.
  • Questions & Answers.

Who Will Benefit:

The following individuals or disciplines will benefit from attending this Webinar:
  • Senior executives of pharmaceutical and device firms
  • Quality Unit Vice Presidents, Directors and Managers
  • Vice presidents, Directors and Managers of operations
  • Quality engineers and field auditors
  • Regulatory and Compliance Management
  • Consultants
  • Quality System Auditors

Instructor Profile:
Dennis M. Moore, is the President CEO and Founder of AUK Technical Services LTD (ATS). a worldwide consulting firm which specializes in Quality Systems and submissions for medical device and pharmaceutical companies. Mr. Moore is a former 22 year FDA credentialed Government investigator, Retired Peace Officer and author of many articles on quality system concepts. Mr. Moore has performed hundreds of FDA device and drug inspections, and written many FDA 483 and warning letter citations. He also has industry experience on the manufacturer side of the auditing desk.

Bookmark and Share
Refund Policy
 Customer Care
Call  +1-650-620-3937
Fax  +1-650-963-2556
Email  editor@complianceonline.com
Read Frequently Asked Questions
 
 Training Finder
   Find Trainings by Category
Find
 More Training by Dennis Moore
What will FDA expect and request from your firm during Design Control portions of Inspections?
Key differences in Design Control Requirements between ISO13485:2003 and the FDA Quality System Regulation
How to successfully audit software systems, and thereby avoid having FDA write software-related 483's and warning letters
Understanding the new International and FDA accepted Software Development Standard IEC 62304
 Customer Testimonials
This training hasn't been reviewed yet.